Rob Blum
Impact in
- Neurology top 5%
- Myasthenia Gravis and Thymoma
- Neuroblastoma Research and Treatments
-
- Pituitary Gland Disorders and Treatments
Papers in
- Oncology 5
- COVID-19 and healthcare impacts 2
- Cancer Treatment and Pharmacology 1
- Co-authors
- Seena C. Aisner (2 shared papers)Robert B. Livingston (2 shared papers)Patrick J. Loehrer (1 shared paper)KyungMann Kim (1 shared paper)Lawrence Einhorn (1 shared paper)David H. Johnson (1 shared paper)Rodney J. Hicks (2 shared papers)John F. Seymour (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Supportive Care in Cancer (1 paper)European Journal Of Haematology (1 paper)The Lancet (1 paper)Journal of Medical Imaging and Radiation Oncology (1 paper)
- Partner nations
- AustraliaUnited States
In The Last Decade
Rob Blum
6 papers receiving 333 citations
Peers
Comparison fields: 5 of 39
- Neurology 220
- Endocrinology, Diabetes and Metabolism 111
- Hematology 40
- Epidemiology 118
- Oncology 74
Countries citing papers authored by Rob Blum
This map shows the geographic impact of Rob Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Blum more than expected).
Fields of papers citing papers by Rob Blum
This network shows the impact of papers produced by Rob Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Blum. The network helps show where Rob Blum may publish in the future.
Co-authors
The 25 scholars most cited alongside Rob Blum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 218 | |
| 2 | 2013 | 56 | |
| 3 | 2003 | 51 | |
| 4 | Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. | 2000 | 7 |
| 5 | 2022 | 7 | |
| 6 | 2022 | 1 |
About Rob Blum
Rob Blum is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Neurology, having authored 6 papers that have together received 340 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (2 papers), Cancer Treatment and Pharmacology (1 paper), Patient Satisfaction in Healthcare (1 paper), Pituitary Gland Disorders and Treatments (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Medical Imaging Techniques and Applications (1 paper), Testicular diseases and treatments (1 paper) and Telemedicine and Telehealth Implementation (1 paper). The work is most often cited by research in Neurology (220 citations), Endocrinology, Diabetes and Metabolism (111 citations), Hematology (40 citations), Epidemiology (118 citations) and Oncology (74 citations). Rob Blum has collaborated with scholars based in Australia and United States. Frequent co-authors include Seena C. Aisner, Robert B. Livingston, Patrick J. Loehrer, KyungMann Kim, Lawrence Einhorn, David H. Johnson, Rodney J. Hicks, John F. Seymour, Linda Mileshkin and A. Patrikeos. Their work appears in journals such as Journal of Clinical Oncology, Supportive Care in Cancer, European Journal Of Haematology, The Lancet and Journal of Medical Imaging and Radiation Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.